Epidemiology and transmission of hepatitis B and C viruses in Kazakhstan

World Journal of Gastroenterology

Volumn 13, Issue 8, 2007, Pages 1204-1207

  Nurgalieva, Zhannat Z ^a,b   Hollinger, F Blaine ^b   Graham, David Y ^b,c   Zhangabylova, S ^a   Zhangbylov, Abai ^a  

^a ASFENDIYAROV KAZAKH NATIONAL MEDICAL UNIVERSITY   (Kazakhstan)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Hepatitis B virus; Kazakhstan; Sero epidemiology; Transmission; Viral hepatitis B; Viral hepatitis C

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AGE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; KAZAKHSTAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NEEDLE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; VIRAL CONTAMINATION; VIRUS TRANSMISSION; VOLUNTEER;

EID: 34247130117     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i8.1204     Document Type: Article

References (21)

1. The European health report. World Health Organization 2005: Public health action for healthier children and populations. http://www.euro.who.int/ehr2005/20050809_1
2. WHO Global Infobase Online: National/Subnational country profiles. Kazakhstan: WHO Estimates of country level mortality. http://www.who.int/ ncd_surveillance/infobase/web
3. Kruglov IV, Iashina TL, Tsvetova GV, Seliutina IA, Klimkin AIu, Aksenova NF, Sobina GV, Gerasimenko NA, Bakulin VS, Ivanov SV. The spread of hepatitis B and C markers and the etiological structure of the morbidity with acute viral hepatitis of the population in the Kuznetsk Basin and northwestern Kazakhstan. Zh Mikrobiol Epidemiol Immunobiol 1995; 6: 36-37
4. Glikberg F, Brawer-Ostrovsky J, Ackerman Z. Very high prevalence of hepatitis B and C in Bukharian Jewish immigrants to Israel. J Clin Gastroenterol 1997; 24: 30-33
5. Hoffmann G, Berglund G, Elmstahl S, Eriksson S, Verbaan H, Widell A, Lindgren S. Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population. Scand J Gastroenterol 2000; 35: 861-865
6. Gay NJ, Hesketh LM, Osborne KP, Farrington CP, Morgan-Capner P, Miller E. The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect 1999; 122: 133-138
7. Tsega E, Mengesha B, Hansson BG, Lindberg J, Nordenfelt E. Hepatitis A, B, and delta infection in Ethiopia: a serologic survey with demographic data. Am J Epidemiol 1986; 123: 344-351
8. Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, Mirza S, Malik T, Fisher-Hoch S, McCormick JB. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ 2000; 78: 956-963
9. Tassaduqe K, Muhammad, Abdus S, Humera K, Asma S, Soban U. Studies on the prevalence of hepatitis B virus in relation to sex, age, promotive factors, associated symptoms and season among human urban population of Multan, Pakistan. J Biol Sci 2004; 4: 183-187
10. Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ 2003; 327: 1075
11. Loukina TN. Current treatment methods for the respiratory infections in children. Thesis for the degree of candidate of medical sciences. Moscow: Institute of Pediatrics, 1993
12. Stekolschikova IA. Diagnostic and treatment tactics in the management of ARI in children. Thesis for the degree of candidate of medical sciences. Moscow: Institute of Pediatrics, RAMS, 1993
13. Shiels MT, Taswell HF, Czaja AJ, Nelson C, Swenke P. Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. Gastroenterology 1987; 93: 675-680
14. Heijtink RA, van Hattum J, Schalm SW, Masurel N. Co-occurrence of HBsAg and anti-HBs: two consecutive infections or a sign of advanced chronic liver disease? J Med Virol 1982; 10: 83-90
15. Tsang TK, Blei AT, O'Reilly DJ, Decker R. Clinical significance of concurrent hepatitis B surface antigen and antibody positivity. Dig Dis Sci 1986; 31: 620-624
16. Wang YM, Ng WC, Kang JY, Yap I, Seet BL, Teo J, Smith R, Guan R. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs. Singapore Med J 1996; 37: 150-152
17. Ohba K, Mizokami M, Kato T, Ueda R, Gurtsenvitch V, Senyuta N, Syrtsev A, Zoya K, Yamashita M, Hayami M. Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia. Epidemiol Infect 1999; 122: 139-143
18. Coleman PF. Surveillance for hepatitis B surface antigen mutants. J Med Virol 2006; 78 Suppl 1: S56-S58
19. Galetskii SA, Seniuta NB, Syrtsev AV, Abdullaev OM, Aliev DA, Kerimov AA, Yamashita M, Hayami M, Kato T, Mizokami M. Analysis of some viral infections, transmitted by parenteral and sexual routes, in the Republic of Azerbaijan. Vopr Virusol 1999; 44: 232-236
20. Pasha O, Luby SP, Khan AJ, Shah SA, McCormick JB, Fisher-Hoch SP. Household members of hepatitis C virus-infected people in Hafizabad, Pakistan: infection by injections from health care providers. Epidemiol Infect 1999; 123: 515-518
21. Seeff LB, Hollinger FB, Alter HJ, Wright EC, Cain CM, Buskell ZJ, Ishak KG, Iber FL, Toro D, Samanta A, Koretz RL, Perrillo RP, Goodman ZD, Knodell RG, Gitnick G, Morgan TR, Schiff ER, Lasky S, Stevens C, Vlahcevic RZ, Weinshel E, Tanwandee T, Lin HJ, Barbosa L. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology 2001; 33: 455-463